Biotech-Focused Fund Adds Million: Immunome Bet Surges
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
We cover the top budgeting pitfalls and simple methods to prevent them, helping you maintain accuracy and momentum in your plan.
17,089 articlesA leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Newmont faced a sharp one-day decline as gold trends shifted and market risks crept in. This article breaks down the ...
With the federal budget facing a revenue shortfall, Congress has less than 150 days to decide on tariffs tied to Trum...
If SpaceX goes public, investors will chase big headlines and big moves. History suggests year-one volatility is the ...
As 2026 unfolds with higher volatility, analysts flag a trio of ETFs that may help retirees balance income and risk. ...
Oracle reports a surge in cloud revenue and record backlog, but shares drift. Market talk centers on whether AI infra...
Investors are rechecking fintech momentum as the stock market today, feb. delivers a choppy session. This guide break...
As the AI build-out accelerates, Marvell and Micron report results that highlight two distinct routes to profit: cust...
With prediction markets signaling a modest chance of beating estimates, Beyond Meat investors are weighing whether th...
A new Washington state law requires residential listings to be publicly marketed, limiting private and exclusive sale...
A new Nvidia platform called Vera Rubin could redefine AI economics for data centers. This piece breaks down what Ver...
Investors weigh a massive AI financing move and its impact on a major server maker’s backlog. This piece explains wha...